North America Cough Syrup Market Report 2021: Increasing Cases of Respiratory Issues are Providing Lucrative Opportunities - Forecast to 2026 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

The North America Cough Syrup Market is expected to witness market growth of 4.5% CAGR during the forecast period (2020-2026).

The increasing cases of respiratory issues are providing lucrative opportunities for the cough syrup market. Moreover, the rising population of old age people along with increasing air pollution are driving the growth of the market. However, the misuse of cough syrup coupled with the strict rules & regulations by the government will restrict the market growth. On the other hand, the high market potential of the developing regions will garner more growth opportunities for the cough syrup market growth.

Cough syrups witnesses a surge in demand due to their wide usage for curing common cold, URTI, and hay fever. Moreover, the increasing disposable income of people in emerging nations will also contribute to the rising growth of the global cough syrups market. In addition, the growing geriatric population will also open various growth prospects for the market.

These cough syrups are prescribed by doctors which are consumed by patients having symptoms like runny nose, common cold, sneezing, and some respiratory infections. In the covid-19 pandemic, people who get infected by the virus shows certain symptoms, among which cough & common cold is the most common one. Many doctors & scientists stated that cough syrup has pro-viral properties which are not good for people who get infected by covid-19.

The US market dominated the North America Combination Medications Market by Country in 2019, and is expected to continue to be a dominant market till 2026. The Canada market is experiencing a CAGR of 5.2% during (2020 - 2026). Additionally, The Mexico market is expected to witness a CAGR of 4.3% during (2020 - 2026).

The Adult market dominated the Canada Cough Syrup Market by Age Group in 2019, thereby, achieving a market value of $195.9 million by 2026. Additionally, The Pediatric market is expected to witness highest CAGR of 8.1% during (2020 - 2026).

Key companies profiled in the report include

• Pfizer, Inc.
• Novartis AG
• Merck Group
• Johnson and Johnson
• GlaxoSmithKline PLC (GSK)
• The Procter and Gamble Company
• Reckitt Benckiser Group PLC
• Abbott Laboratories
• Sanofi S.A.
• Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC)

Scope of the Study

Market Segments covered in the Report:

By Product

• Cough Suppressants
• Combination Medications
• Expectorants

By Age Group

• Adult
• Pediatric

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Strategies deployed in Cough Syrup Market

Chapter 4. North America Cough Syrup Market by Product

Chapter 5. North America Cough Syrup Market by Age Group

Chapter 6. North America Cough Syrup Market by Distribution Channel

Chapter 7. North America Cough Syrup Market by Country

Chapter 8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/xqne4p